Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2026-04-08 @ 2:36 PM
Study NCT ID:
NCT00106002
Status:
COMPLETED
Last Update Posted:
2009-06-01
First Post:
2005-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
9028
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Chief Medical Officer
Old Organization:
Eli Lilly